1. Home
  2. ROAD vs LEGN Comparison

ROAD vs LEGN Comparison

Compare ROAD & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Construction Partners Inc.

ROAD

Construction Partners Inc.

HOLD

Current Price

$115.07

Market Cap

6.2B

Sector

Industrials

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$22.26

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROAD
LEGN
Founded
2001
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
5.9B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
ROAD
LEGN
Price
$115.07
$22.26
Analyst Decision
Buy
Strong Buy
Analyst Count
5
13
Target Price
$122.20
$69.33
AVG Volume (30 Days)
470.0K
2.1M
Earning Date
02-05-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
40.46
N/A
EPS
1.84
N/A
Revenue
$2,812,356,000.00
$909,045,000.00
Revenue This Year
$25.23
$68.20
Revenue Next Year
$10.22
$47.77
P/E Ratio
$60.94
N/A
Revenue Growth
54.20
74.75
52 Week Low
$64.79
$20.21
52 Week High
$138.90
$45.30

Technical Indicators

Market Signals
Indicator
ROAD
LEGN
Relative Strength Index (RSI) 56.53 43.65
Support Level $108.29 $20.21
Resistance Level $116.78 $24.12
Average True Range (ATR) 4.83 1.05
MACD 0.16 0.31
Stochastic Oscillator 73.43 52.43

Price Performance

Historical Comparison
ROAD
LEGN

About ROAD Construction Partners Inc.

Construction Partners Inc operates as a civil infrastructure company. It specializes in the construction and maintenance of roadways. The company through its subsidiaries, provides various products and services to both public and private infrastructure projects, with an emphasis on highways, roads, bridges, airports, and commercial and residential developments. Its operations consist of manufacturing and distributing hot mix asphalt, paving activities, including the construction of roadway base layers and application of asphalt pavement, site development, including the installation of utility and drainage systems, and others. The company has a single segment which predominantly consists of infrastructure and road construction, and operates across various states in the United States.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: